# Arbutus Biopharma Corp: Form 8-K, filed Jan 17, 2018

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2018-01-17
- Accepted by EDGAR: Jan 17, 2018, 16:39 ET
- Period: 2018-01-11
- Accession: 0000912282-18-000013
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000091228218000013/arbutus8k_011718.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000091228218000013/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000091228218000013/arbutus8k_011718.htm

Filed Jan 17, 2018.
Source: SEC EDGAR, the filing index for accession 0000912282-18-000013. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.